Serum Long Noncoding RNA Urothelial Carcinoma-associated 1: A Novel Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2017 Sep 1

PMID 28856933

Citations 39

Authors

Zhi-Kun Zheng

Cui Pang

Yang Yang

Qiong Duan

Ju Zhang

Wen-Chao Liu

Affiliations

Soon will be listed here.

Abstract

Objective Long noncoding RNAs (lncRNAs) offer great potential as cancer biomarkers. This study was performed to assess the applicability of serum lncRNA urothelial carcinoma-associated 1 (UCA1) as a diagnostic and/or prognostic biomarker for hepatocellular carcinoma (HCC). Methods We examined UCA1 expression in serum samples from 105 patients with HCC, 105 patients with benign liver disease (BLD), and 105 healthy volunteers using reverse-transcription polymerase chain reaction and analyzed the relationship between serum UCA1 and clinicopathological parameters of HCC as well as survival. Results Expression of serum UCA1 was significantly higher in patients with HCC and allowed for discrimination of HCC from BLD and healthy controls. High expression of serum UCA1 was significantly associated with a high tumor grade, large tumor size, positive vascular invasion, and advanced TNM stage. Multivariate analysis revealed that a high serum UCA1 level was an independent unfavorable prognostic factor for HCC. Conclusions Our results confirm the upregulation of serum UCA1 expression in HCC and indicate its clinical value as a noninvasive biomarker for HCC screening and prognostic prediction.

Citing Articles

Toward the use of nanopore RNA sequencing technologies in the clinic: challenges and opportunities.

Katopodi X, Begik O, Novoa E Nucleic Acids Res. 2025; 53(5).

PMID: 40057374 PMC: 11890063. DOI: 10.1093/nar/gkaf128.

Diagnosis of the Initial Stage of Hepatocellular Carcinoma: A Review.

Sharma K, Mohsin M, Mittal P, Ali Z, Fatma N, Upadhyay P Curr Pharm Des. 2024; 30(22):1708-1724.

PMID: 38797901 DOI: 10.2174/0113816128298875240321073907.

The role of long non-coding RNA in hepatocellular carcinoma.

Liang W, Zhao Y, Meng Q, Jiang W, Deng S, Xue J Aging (Albany NY). 2024; 16(4):4052-4073.

PMID: 38334963 PMC: 10929815. DOI: 10.18632/aging.205523.

Combinatorial Gene Expression Profiling of Serum , , and lncRNAs to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic Review and Meta-Analysis.

Lumkul L, Jantaree P, Jaisamak K, Wongkummool W, Lapisatepun W, Orrapin S Int J Mol Sci. 2024; 25(2).

PMID: 38279264 PMC: 10816616. DOI: 10.3390/ijms25021258.

Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value.

Shehab-Eldeen S, Essa A, Arafat E, Sleem A, Alhosary A, Darwish E Biologics. 2023; 17:137-149.

PMID: 37854341 PMC: 10581015. DOI: 10.2147/BTT.S433872.

References

Na X, Liu Z, Ren P, Yu R, Shang X . Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4-KRT6/13 signaling pathway. Int J Clin Exp Med. 2015; 8(8):12609-16. PMC: 4612857. View

He Z, Wang Y, Huang G, Wang Q, Zhao D, Chen L . The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP. Arch Biochem Biophys. 2017; 623-624:1-8. DOI: 10.1016/j.abb.2017.01.013. View

Li W, Xie P, Ruan W . Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis. J Bone Oncol. 2016; 5(2):80-5. PMC: 4908186. DOI: 10.1016/j.jbo.2016.05.003. View

Wen J, Ma Y, Yang G, Wang G . Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma. Eur Rev Med Pharmacol Sci. 2017; 21(3):498-503. View

Wang H, Lu J, Chen W, Gu A . Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely related to clinical diagnosis as a predictive biomarker in plasma. Int J Clin Exp Med. 2015; 8(7):11824-30. PMC: 4565407. View

Diaz-Gonzalez A, Forner A, Rodriguez de Lope C, Varela M . New challenges in clinical research on hepatocellular carcinoma. Rev Esp Enferm Dig. 2015; 108(8):485-93. DOI: 10.17235/reed.2015.4012/2015. View

Hu J, Song W, Zhang S, Shen X, Qiu X, Wu H . HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling. Sci Rep. 2016; 6:23521. PMC: 4806364. DOI: 10.1038/srep23521. View

Mang Y, Li L, Ran J, Zhang S, Liu J, Li L . Long noncoding RNA NEAT1 promotes cell proliferation and invasion by regulating hnRNP A2 expression in hepatocellular carcinoma cells. Onco Targets Ther. 2017; 10:1003-1016. PMC: 5325106. DOI: 10.2147/OTT.S116319. View

Zhou Y, Wang X, Zhang J, He A, Wang Y, Han K . Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184. Oncotarget. 2017; 8(11):18260-18270. PMC: 5392325. DOI: 10.18632/oncotarget.15353. View

10.

Zhou T, Gao Y . Increased expression of LncRNA BANCR and its prognostic significance in human hepatocellular carcinoma. World J Surg Oncol. 2016; 14(1):8. PMC: 4709863. DOI: 10.1186/s12957-015-0757-5. View

11.

Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F . Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling. FEBS J. 2014; 281(7):1750-8. DOI: 10.1111/febs.12737. View

12.

Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X . LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2012; 41(Database issue):D983-6. PMC: 3531173. DOI: 10.1093/nar/gks1099. View

13.

Zheng C, Hao H, Chen L, Shao J . Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Clin Transl Oncol. 2017; 19(8):961-968. DOI: 10.1007/s12094-017-1626-1. View

14.

Tantai J, Hu D, Yang Y, Geng J . Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Int J Clin Exp Pathol. 2015; 8(7):7887-95. PMC: 4555681. View

15.

Li Y, Li W, Liang B, Li L, Wang L, Huang H . Identification of cancer risk lncRNAs and cancer risk pathways regulated by cancer risk lncRNAs based on genome sequencing data in human cancers. Sci Rep. 2016; 6:39294. PMC: 5171637. DOI: 10.1038/srep39294. View

16.

Wang F, Ying H, He B, Pan Y, Deng Q, Sun H . Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway. Oncotarget. 2015; 6(10):7899-917. PMC: 4480724. DOI: 10.18632/oncotarget.3219. View

17.

Cao C, Zhang T, Zhang D, Xie L, Zou X, Lei L . The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma. Oncogene. 2016; 36(8):1112-1122. DOI: 10.1038/onc.2016.278. View

18.

Liu H, Wang G, Yang L, Qu J, Yang Z, Zhou X . Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway. PLoS One. 2016; 11(12):e0168406. PMC: 5158064. DOI: 10.1371/journal.pone.0168406. View

19.

Collier J, Sherman M . Screening for hepatocellular carcinoma. Hepatology. 1998; 27(1):273-8. DOI: 10.1002/hep.510270140. View

20.

Bian Z, Jin L, Zhang J, Yin Y, Quan C, Hu Y . LncRNA-UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p. Sci Rep. 2016; 6:23892. PMC: 4820696. DOI: 10.1038/srep23892. View